Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin

PURPOSE: Noninvasive beta cell mass (BCM) quantification is a crucial tool to understand diabetes development and progression. [(111)In]exendin is a promising agent for in vivo beta cell imaging, but tracer testing has been hampered by the lack of well-defined rodent models. PROCEDURES: Biodistribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Willekens, Stefanie M. A., Joosten, Lieke, Boerman, Otto C., Balhuizen, Alexander, Eizirik, Decio L., Gotthardt, Martin, Brom, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010585/
https://www.ncbi.nlm.nih.gov/pubmed/26886298
http://dx.doi.org/10.1007/s11307-016-0936-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010585/
https://www.ncbi.nlm.nih.gov/pubmed/26886298
http://dx.doi.org/10.1007/s11307-016-0936-y

Ejemplares similares